P. Portolés

发表

Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.

P. Portolés, G. de Ojeda, G. Criado, 1999, Cellular immunology.

CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.

U. Dianzani, R. Flavell, C. Dong, 2008, International immunology.

CD4+ T Cells: Specificity and Function

C. Janeway, J. West, S. Carding, 1988, Immunological reviews.

Dissociation of actin polymerization and lipid raft accumulation by ligation of the Inducible Costimulator (ICOS, CD278)

U. Dianzani, M. P. Zafra, P. Portolés, 2012 .

Complement regulatory protein Crry/p65 costimulation expands natural treg cells with enhanced suppressive properties in proteoglycan-induced arthritis.

W. van Eden, F. Broere, P. Portolés, 2011, Arthritis and rheumatism.

Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection.

C. Janeway, U. Dianzani, E. Reich, 1989, Cold Spring Harbor symposia on quantitative biology.

NF‐κB in Th2 cells : delayed and long‐lasting induction through the TCR complex

P. Portolés, B. Dorado, S. Ballester, 1998 .

Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.

C. Janeway, A. Golby, M. Bonneville, 1989, Journal of immunology.

Loss of N-terminal Charged Residues of Mouse CD3ϵ Chains Generates Isoforms Modulating Antigen T Cell Receptor-mediated Signals and T Cell Receptor-CD3 Interactions*

P. Portolés, J. Rojo, M. Feito, 2007, Journal of Biological Chemistry.

Mechanisms of H4/ICOS costimulation: effects on proximal TCR signals and MAP kinase pathways

A. Chiocchetti, U. Dianzani, R. Vaschetto, 2003, European journal of immunology.

CD4 Dependence of Activation Threshold and TCR Signalling in Mouse T Lymphocytes

R. Díez-Orejas, P. Portolés, G. Criado, 1997, Scandinavian journal of immunology.

The Co‐Receptor Function of Murine CD4 1

C. Janeway, U. Dianzani, J. Tite, 1989 .

Inhibition of the responses of a cloned CD4 T cell line to different class II major histocompatibility complex ligands by anti‐CD4 and by anti‐receptor Fab fragments are directly related

C. Janeway, P. Portolés, Charles A. Janeway, 1989, European journal of immunology.

Complement regulatory protein Crry/p65‐mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts

J. Madrenas, P. Portolés, G. Criado, 2005, Journal of leukocyte biology.

Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand

U. Dianzani, Y. Arimura, P. Portolés, 2021, Journal of leukocyte biology.

N-terminal negatively charged residues in CD3varepsilon chains as a phylogenetically conserved trait potentially yielding isoforms with different isoelectric points: analysis of human CD3varepsilon chains.

P. Portolés, J. Rojo, M. Feito, 2009, Immunology letters.

T-cell receptor.

P. Portolés, J. Rojo, Raquel Bello, 2008, Advances in experimental medicine and biology.

The TCR/CD3 complex: molecular interactions in a changing structure.

P. Portolés, J. Rojo, M. Feito, 2002, Archivum immunologiae et therapiae experimentalis.

The co-receptor function of murine CD4.

C. Janeway, U. Dianzani, J. Tite, 1989, Immunological reviews.

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals

E. López-Granados, E. Guccione, A. Bertoletti, 2021, bioRxiv.

Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278)

U. Dianzani, M. P. Zafra, P. Portolés, 2011, Cellular and Molecular Life Sciences.

Polyerga, a biological response modifier enhancing T-lymphocyte-dependent responses

P. Portolés, J. Rojo, M. Feito, 1994, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

Characterization of H4: a mouse T lymphocyte activation molecule functionally associated with the CD3/T cell receptor

C. Janeway, U. Dianzani, S. Bonissoni, 1996, European journal of immunology.

PI3-Kinase p110α Deficiency Modulates T Cell Homeostasis and Function and Attenuates Experimental Allergic Encephalitis in Mature Mice

U. Dianzani, P. Portolés, J. Rojo, 2021, International journal of molecular sciences.

The PI-3-Kinase P110α Catalytic Subunit of T Lymphocytes Modulates Collagen-Induced Arthritis

P. Portolés, G. Criado, J. Rojo, 2021, International journal of molecular sciences.

Recognition of MHC Class II Antigens by the CD4: T Cell Receptor Complex

C. Janeway, J. Tite, P. Portolés, 1987 .

A simple method for the radioactive iodination of CD4 molecules.

C. Janeway, P. Portolés, J. Rojo, 1990, Journal of immunological methods.

Genetic and immunochemical evidence for CD4‐dependent association of p56lck with the alpha beta T‐cell receptor (TCR): regulation of TCR‐induced activation.

P. Portolés, G. Criado, J. Rojo, 1994, The EMBO journal.

Modulation of lymphocyte interaction with endothelium and homing by HIV-1 gp120.

U. Dianzani, F. Malavasi, S. Bonissoni, 1997, Journal of immunology.

A symmetrical view of the T-cell receptor-CD3 complex.

P. Portolés, J. Rojo, 1991, Immunology today.

Effects of 3D nanocomposite bioceramic scaffolds on the immune response.

M. Vallet‐Regí, I. Izquierdo-Barba, P. Portolés, 2014, Journal of materials chemistry. B.

Interaction of an ordered mesoporous bioactive glass with osteoblasts, fibroblasts and lymphocytes, demonstrating its biocompatibility as a potential bone graft material.

M. Vallet‐Regí, M. Alcaide, D. Arcos, 2010, Acta biomaterialia.

An Immunological Approach to the Biocompatibility of Mesoporous SiO2-CaO Nanospheres

M. Vallet‐Regí, D. Arcos, P. Portolés, 2020, International journal of molecular sciences.

Inhibitory mechanisms of 5-fluorodeoxyuridine on mitogen-induced blastogenesis of lymphocytes.

P. Portolés, G. de Ojeda, J. Rojo, 1984, International Journal of Immunopharmacology.

T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response

U. Dianzani, P. Portolés, J. Rojo, 2018, Front. Immunol..

ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.

J. Herranz, U. Dianzani, C. Blanco-Aparicio, 2016, Biochemical pharmacology.

ICOS deficiency hampers the homeostasis, development and function of NK cells

U. Dianzani, P. Portolés, J. Rojo, 2019, PloS one.

Suppression of CD4+ T Lymphocyte Activation in Vitro and Experimental Encephalomyelitis in Vivo by the Phosphatidyl Inositol 3-Kinase Inhibitor PIK-75

U. Dianzani, P. Portolés, J. Rojo, 2014, International journal of immunopathology and pharmacology.

Crry/p65, a Membrane Complement Regulatory Protein, Has Costimulatory Properties on Mouse T Cells1

P. Portolés, G. de Ojeda, E. Fernández-Centeno, 2000, The Journal of Immunology.

H4/ICOS: a costimulatory protein in the right place at the right time?

U. Dianzani, P. Portolés, J. Rojo, 2001 .

Immune recognition and effector function in subsets of CD4 T cells.

C. Janeway, M. Luqman, S. Carding, 1988, Princess Takamatsu symposia.

Characteristics of TCR/CD3 complex CD3ɛ chains of regulatory CD4+ T (Treg) lymphocytes: role in Treg differentiation in vitro and impact on Treg in vivo

P. Portolés, G. Criado, J. Rojo, 2014, Journal of leukocyte biology.

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

E. López-Granados, V. Pothula, E. Guccione, 2021, Cell Reports.

Asymmetry in the recognition of antigen: self class II MHC and non-self class II MHC molecules by the same T-cell receptor.

C. Janeway, P. Portolés, J. Rojo, 1989, The Journal of molecular and cellular immunology : JMCI.

The renaissance of T regulatory cells: Looking for markers in a haystack

P. Portolés, Eliana Pini, G. Ojeda, 2007 .

Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV‐1 gp120

U. Dianzani, A. Pileri, F. Malavasi, 1995, European journal of immunology.

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

A. Borobia, A. Carcas, J. Frías, 2021, The Lancet.

Enhancement of lymphocyte proliferation, interleukin-2 production and NK activity by inmunoferon (AM-3), a fungal immunomodulator: variations in normal and immunosuppressed mice.

I. Barasoain, P. Portolés, J. Rojo, 1986, International journal of immunopharmacology.

Autoreactivity of low but not of high CD4 variants of an antigen-specific, I-A-restricted mouse T cell clone.

K. Eichmann, P. Portolés, S. Suzuki, 1992, Journal of immunology.

CD28 is expressed by macrophages with anti‐inflammatory potential and limits their T‐cell activating capacity

A. Puig-Kröger, Á. Corbí, P. Portolés, 2020, European journal of immunology.

Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination

E. Guccione, J. Ochando, E. González-Parra, 2022, Frontiers in Immunology.

A hyperreactive variant of a CD4+ T cell line is activated by syngeneic antigen presenting cells in the absence of antigen.

P. Portolés, J. Rojo, M. Feito, 1995, Cellular immunology.

Properties on Mouse T Cells Regulatory Protein, Has Costimulatory Crry/p65, a Membrane Complement

P. Portolés, E. Fernández-Centeno, J. Rojo, 2017 .

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination

J. Ochando, E. González-Parra, M. Pérez-Olmeda, 2023, Pharmaceuticals.

The TCR/CD3 complex: opening the gate to successful vaccination.

P. Portolés, J. Rojo, 2009, Current pharmaceutical design.

Variability of invariant mouse CD3ϵ chains detected by anti‐CD3 antibodies

C. Janeway, P. Portolés, G. Criado, 2000 .